Loading...
Dernières publications
-
Dylan Moutachi, Janek Hyzewicz, Pauline Roy, Mégane Lemaitre, Damien Bachasson, et al.. Treadmill running and mechanical overloading improved the strength of the plantaris muscle in the dystrophin‐desmin double knockout (DKO) mouse. The Journal of Physiology, In press, ⟨10.1113/JP286425⟩. ⟨hal-04643936⟩
-
Medhi Hassani, Dylan Moutachi, Mégane Lemaitre, Alexis Boulinguiez, Denis Furling, et al.. Beneficial effects of resistance training on both mild and severe mouse dystrophic muscle function as a preclinical option for Duchenne muscular dystrophy. PLoS ONE, 2024, 19, ⟨10.1371/journal.pone.0295700⟩. ⟨hal-04501283⟩
-
Antonio Atalaia, Dagmar Wandrei, Nawel Lalout, Rachel Thompson, Adrian Tassoni, et al.. EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders. Orphanet Journal of Rare Diseases, 2024, 19 (1), pp.66. ⟨10.1186/s13023-024-03059-3⟩. ⟨hal-04460667⟩
-
Florent Porquet, Lin Weidong, Kévin Jehasse, Hélène Gazon, Maria Kondili, et al.. Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells. Molecular Therapy - Nucleic Acids, 2023, 32, pp.857 - 871. ⟨10.1016/j.omtn.2023.05.007⟩. ⟨hal-04287597⟩
-
Caroline Le Guiner, T Larcher, A Lafoux, G Toumaniantz, S Webb, et al.. Characterization of the muscular and cardiac diseases of the DMSXL mouse model, a transgenic mouse model for Myotonic Dystrophy type 1. American Society of Gene & Cell Therapy, May 2023, LOS ANGELES, United States. ⟨hal-04096181⟩
-
Dylan Moutachi, Mégane Lemaitre, Clément Delacroix, Onnik Agbulut, Denis Furling, et al.. Valproic acid reduces muscle susceptibility to contraction‐induced functional loss but increases weakness in two murine models of Duchenne muscular dystrophy. Clinical and Experimental Pharmacology and Physiology, In press, ⟨10.1111/1440-1681.13804⟩. ⟨hal-04146953⟩
Chiffres clés
140
Publications avec texte intégral
Open Access
53 %
Mots clés
DM1
Dynamin 2
KNOCKOUT MICE
Muscle
Cell model
Transgenic mouse model
BIOLOGIE MOLECULAIRE
Oligodendrocyte
Antisense oligonucleotide
Cytoskeleton
Fibrosis
Glucocorticoids
Cell culture model
Trinucleotide Repeat Expansion
Central nervous system
CMS
Brain
Centronuclear myopathy
ACETYLCHOLINESTERASE
Myotonic Dystrophy Type 1
Glucocorticoid-receptor
Duchenne muscular dystrophy
Long read sequencing
Dystrophin
Brain dysfunction
GABA
MBNL
Skeletal muscle
PCR
Transgenic mouse
Exercise
Acute coronary syndrome
RNA biology
GSK3
Heart
CRISPR/Cas9
In vivo
Acetylcholinesterase knockout mouse
Expression
Acetylcholinesterase deficiency
Astrocytes
Transcriptomics
ARN
Endurance training
Trinucleotide repeat expansion
Genotype phenotype correlation
Alternative splicing
Muscular dystrophy
Gene Therapy
Neuron
Animals
RNA interference
Glutamate
Mouse model
Desmin
Myostatin
Oligodendrocytes
Knockout
Myotonic Dystrophy
Dilated cardiomyopathy
Antisense oligonucleotides
Myotonic dystrophy
Cardiac muscle
Glial cells
Cell penetrating peptide
DMPK
CONGENITAL MYATHENIC SYNDROME
CTG repeats
AAV
Quantitative microdialysis
Dystrophie Myotonique
RNA splicing
Diaphragm
Myotonic dystrophy type 1
Dystrophie myotonique
CTG repeat instability
PacBio
Intermediate filament
Male
Astrocyte
Gene editing
Myotonic Dystrophy type 1
CRISPRi
Humans
Hypoxia
Myotonic dystrophy mouse models
CTG repeat contractions
Maximal force
Motoneuron
Mouse models
Thérapie génique
Mice
Autophagy
Gene therapy
Heart failure
Therapy
Aging
Exercice
Myelin
DMSXL mice